174 related articles for article (PubMed ID: 12408995)
1. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
Sliva D; Labarrere C; Slivova V; Sedlak M; Lloyd FP; Ho NW
Biochem Biophys Res Commun; 2002 Nov; 298(4):603-12. PubMed ID: 12408995
[TBL] [Abstract][Full Text] [Related]
2. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells.
Sliva D; Sedlak M; Slivova V; Valachovicova T; Lloyd FP; Ho NW
J Altern Complement Med; 2003 Aug; 9(4):491-7. PubMed ID: 14499024
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
Sliva D; Rizzo MT; English D
J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
[TBL] [Abstract][Full Text] [Related]
4. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
[TBL] [Abstract][Full Text] [Related]
5. Ganoderma lucidum (Reishi) in cancer treatment.
Sliva D
Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
7. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling.
Jiang J; Slivova V; Harvey K; Valachovicova T; Sliva D
Nutr Cancer; 2004; 49(2):209-16. PubMed ID: 15489214
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
9. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
10. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling.
Jiang J; Grieb B; Thyagarajan A; Sliva D
Int J Mol Med; 2008 May; 21(5):577-84. PubMed ID: 18425349
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells.
Slivova V; Zaloga G; DeMichele SJ; Mukerji P; Huang YS; Siddiqui R; Harvey K; Valachovicova T; Sliva D
Nutr Cancer; 2005; 52(1):66-73. PubMed ID: 16091006
[TBL] [Abstract][Full Text] [Related]
12. Aspirin inhibits highly invasive prostate cancer cells.
Lloyd FP; Slivova V; Valachovicova T; Sliva D
Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion.
Thyagarajan A; Jiang J; Hopf A; Adamec J; Sliva D
Int J Mol Med; 2006 Oct; 18(4):657-64. PubMed ID: 16964420
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells.
Thyagarajan A; Zhu J; Sliva D
Int J Oncol; 2007 Apr; 30(4):963-9. PubMed ID: 17332936
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro.
Yue GG; Fung KP; Tse GM; Leung PC; Lau CB
J Altern Complement Med; 2006 Oct; 12(8):777-89. PubMed ID: 17034284
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
18. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
[TBL] [Abstract][Full Text] [Related]
19. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.
Stanley G; Harvey K; Slivova V; Jiang J; Sliva D
Biochem Biophys Res Commun; 2005 Apr; 330(1):46-52. PubMed ID: 15781230
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]